(Q40264460)

Dataset for "Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine"

19 September 2017

2 references

Continued use of retracted papers: Temporal trends in citations and (lack of) awareness of retractions shown in citation contexts in biomedicine

title

Modulation of Stat3 activation by the cytosolic phospholipase A2alpha and cyclooxygenase-2-controlled prostaglandin E2 signaling pathway (English)

1 reference

19 September 2017

1 reference

Chang Han

1

1 reference

19 September 2017

A Jake Demetris

2

1 reference

19 September 2017

Donna B Stolz

3

1 reference

19 September 2017

Lihong Xu

4

1 reference

19 September 2017

Kyu Lim

5

1 reference

19 September 2017

Tong Wu

6

1 reference

19 September 2017

language of work or name

English

0 references

publication date

21 June 2006

1 reference

Journal of Biological Chemistry

19 September 2017

number of pages

16

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 September 2017

volume

281

1 reference

19 September 2017

issue

34

1 reference

19 September 2017

page(s)

24831-24846

1 reference

Stats: transcriptional control and biological impact

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

STAT proteins: From normal control of cellular events to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

The STATs of cancer--new molecular targets come of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Cholangiocarcinoma: Current concepts and insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

The molecular pathogenesis of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Cyclooxygenase-2-derived prostaglandin E2 promotes human cholangiocarcinoma cell growth and invasion through EP1 receptor-mediated activation of the epidermal growth factor receptor and Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

ERBB-2 overexpression and cyclooxygenase-2 up-regulation in human cholangiocarcinoma and risk conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

COX-2 inhibits Fas-mediated apoptosis in cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Bile acids activate EGF receptor via a TGF-alpha-dependent mechanism in human cholangiocyte cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: implications for biliary tract carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Cyclooxygenase-2 promotes human cholangiocarcinoma growth: evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21waf1/cip1 and p27kip1 and cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Involvement of 85-kd cytosolic phospholipase A(2) and cyclooxygenase-2 in the proliferation of human cholangiocarcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Genetic and pharmacological analysis of prostanoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Prostanoid receptors: subtypes and signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Nuclear localization of prostaglandin E2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Lipopolysaccharide induces cholangiocyte proliferation via an interleukin-6-mediated activation of p44/p42 mitogen-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasias and associated "intestinal-type" biliary cancer chemically induced in rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Relationship between interleukin-6 and proliferation and differentiation in cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Gp130 and the interleukin-6 family of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Interleukin-6: structure-function relationships.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Interleukin 6 and its receptor: ten years later

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Interleukin-6 signal transduction and lymphocyte function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Transforming growth factor-beta (TGF-beta) activates cytosolic phospholipase A2alpha (cPLA2alpha)-mediated prostaglandin E2 (PGE)2/EP1 and peroxisome proliferator-activated receptor-gamma (PPAR-gamma)/Smad signaling pathways in human liver cancer ce

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Co-purification and direct interaction of Ras with caveolin, an integral membrane protein of caveolae microdomains. Detergent-free purification of caveolae microdomains

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Autocrine/paracrine prostaglandin E2 production by non-small cell lung cancer cells regulates matrix metalloproteinase-2 and CD44 in cyclooxygenase-2-dependent invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

OAZ uses distinct DNA- and protein-binding zinc fingers in separate BMP-Smad and Olf signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Nuclear interaction of EGFR and STAT3 in the activation of the iNOS/NO pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

The epidemiology of cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Cellular functions regulated by Src family kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Src tyrosine kinase is a novel direct effector of G proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Role of STATs as downstream signal transducers in Src family kinase-mediated tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Epidermal growth factor receptor-mediated activation of Stat3 during multistage skin carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Angiotensin-II-binding sites on hepatocyte nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Different intracellular locations for prostaglandin endoperoxide H synthase-1 and -2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M602201200

Unexpectedly strong binding of a large metal ion (Bi3+) to human serum transferrin

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

The role of prostaglandin E2 receptors in the pathogenesis of rheumatoid arthritis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

The effect of interleukin-6 (IL-6)/gp130 signalling on biliary epithelial cell growth, in vitro

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis

1 reference

30 December 2023

https://opencitations.net/index/api/v1/references/10.1074/JBC.M602201200

Identifiers

DOI

10.1074/JBC.M602201200

1 reference

19 September 2017

1 reference